EORTC protocol 20971 - 22997

A Phase III randomized study on low-dose total body irradiation and involved field radiotherapy in patients with localized, stages I and II, low grade non-Hodgkin's lymphoma
Trial StatusClosed for recruitment
DatesDate of activation: 25-Jan-01
Closed on : 02-Mar-09
Data management at EORTCFull
Phase3
Randomized trialYes
TypeHemato-malign
Targeted Sample size344
Number of steps1
Drug
Study StaffMarten Beijert (Study Coordinator) - University Medical Center Groningen, Groningen
Pierre Richaud (Study Coordinator) - Institut Bergonie, Bordeaux
Catherine Fortpied (Statistician) - EORTC Headquarters, Brussels
Livia Giurgea (Data Manager) - EORTC Headquarters, Brussels
Hilde Breyssens (Project Manager) - EORTC Headquarters, Brussels, hilde.breyssens( at )eortc.be, +32 27741004
Type of cancerNon Hodgkins Lymphoma
Participating GroupsEORTC Lymphoma Group(Coordinating Group)
EORTC Radiation Oncology Group
Protocol summaryCancer.gov (PDQ)
ClinicalTrials.gov
NCT numberNCT00014326
EudraCT
Protocol documents in PDF
(requires password)
Study documentation
Back to Protocol section